revenue growth of 23% at the expense of 20% decline in earnings does not justify a price earnings of 120. its as simple as that. there are better opportunities.
- Forums
- ASX - By Stock
- Ann: 2020 Full Year Results
revenue growth of 23% at the expense of 20% decline in earnings...
- There are more pages in this discussion • 60 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NAN (ASX) to my watchlist
(20min delay)
|
|||||
Last
$2.81 |
Change
0.000(0.00%) |
Mkt cap ! $851.3M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 956 | $2.97 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.67 | 1665 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 466 | 3.030 |
2 | 6943 | 2.950 |
4 | 494 | 2.900 |
2 | 1610 | 2.890 |
1 | 1284 | 2.860 |
Price($) | Vol. | No. |
---|---|---|
2.670 | 1480 | 1 |
2.760 | 1033 | 6 |
2.790 | 3200 | 3 |
2.820 | 1800 | 1 |
2.830 | 2867 | 2 |
Last trade - 10.05am 07/05/2024 (20 minute delay) ? |
|
|||||
Last
$2.87 |
  |
Change
0.000 ( 2.16 %) |
|||
Open | High | Low | Volume | ||
$2.84 | $2.88 | $2.84 | 4551 | ||
Last updated 10.26am 07/05/2024 ? |
Featured News
NAN (ASX) Chart |
Day chart unavailable
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, CEO
Steven Gourlay
CEO
Previous Video
Next Video
SPONSORED BY The Market Online